Immuron (IMRN) Total Current Liabilities (2016 - 2025)
Immuron (IMRN) recorded quarterly Total Current Liabilities of $19662.1 in Q3 2025, down 98.44% quarter-over-quarter from $1.3 million in Q2 2025, and down 27.15% on a YoY basis from $26989.8 in Q3 2024.
Immuron (IMRN) Total Current Liabilities (2016 - 2025) Analysis & Trends
Immuron's Total Current Liabilities history runs 10 years deep, the most recent figure standing at $19662.1 for Q3 2025.
- In Q3 2025, Total Current Liabilities fell 27.15% year-over-year to $19662.1; the TTM figure through Sep 2025 stood at $19662.1 (down 27.15% YoY), while the FY2025 annual figure was $19662.1, down 27.15% from the prior year.
- Total Current Liabilities was $19662.1 for Q3 2025 at Immuron, down from $1.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.8 million in Q2 2024 to a low of $14477.7 in Q4 2023.
- Historically, Total Current Liabilities has averaged $855990.8 across 5 years, with a median of $1.0 million in 2022.
- The sharpest annual moves came in 2021 and 2023: Total Current Liabilities surged 16645.17% in 2021, then tumbled 98.53% in 2023.
- A 5-year view of Total Current Liabilities shows it stood at $821216.7 in 2021, then rose by 20.25% to $987488.0 in 2022, then sank by 98.53% to $14477.7 in 2023, then surged by 7708.68% to $1.1 million in 2024, then sank by 98.26% to $19662.1 in 2025.
- The last three Total Current Liabilities figures came in at $19662.1 (Q3 2025), $1.3 million (Q2 2025), and $1.1 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | 19,662.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 19,662.09 |
| Jun 30, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 9, 2024 | 26,989.79 |
| Jun 30, 2024 | 1.78 Mn |
| Dec 31, 2023 | 14,477.66 |
| Sep 28, 2023 | 1.45 Mn |
| Aug 30, 2023 | 22,191.39 |
| Jun 30, 2023 | 1.48 Mn |
| Dec 31, 2022 | 987,488.00 |
| Aug 31, 2022 | 1.05 Mn |
| Jun 30, 2022 | 1.08 Mn |
| Dec 31, 2021 | 821,216.68 |
| Jun 30, 2021 | 863,888.67 |
| Dec 31, 2020 | 4,904.20 |
| Sep 1, 2020 | 516,411.00 |
| Jun 30, 2020 | 338,466.42 |
| Dec 31, 2019 | 5,164.11 |
| Jun 30, 2019 | 837,436.32 |
| Dec 31, 2018 | 803,338.00 |